These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
535 related items for PubMed ID: 22177546
1. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009. Morfin-Otero R, Dowzicky MJ. Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546 [Abstract] [Full Text] [Related]
2. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Bertrand X, Dowzicky MJ. Clin Ther; 2012 Jan; 34(1):124-37. PubMed ID: 22154196 [Abstract] [Full Text] [Related]
3. In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Wang YF, Dowzicky MJ. Diagn Microbiol Infect Dis; 2010 Sep; 68(1):73-9. PubMed ID: 20727474 [Abstract] [Full Text] [Related]
4. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. Navon-Venezia S, Leavitt A, Carmeli Y. J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223 [Abstract] [Full Text] [Related]
5. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan. Liu JW, Wang LS, Cheng YJ, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Chuang YC, Lin HC, Shi ZY, Kung HC, Huang CH, Tsao SM, Lu CT, Liao CH, Hsueh PR. Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353 [Abstract] [Full Text] [Related]
11. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ. J Antimicrob Chemother; 2007 Nov; 60(5):1018-29. PubMed ID: 17855724 [Abstract] [Full Text] [Related]
12. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011. Kanj SS, Whitelaw A, Dowzicky MJ. Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313 [Abstract] [Full Text] [Related]
14. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007). Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ. Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205 [Abstract] [Full Text] [Related]
18. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010. Balode A, Punda-Polić V, Dowzicky MJ. Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898 [Abstract] [Full Text] [Related]